Update on Procedure-Related Risks for Prenatal Diagnosis Techniques

被引:261
作者
Tabor, Ann [1 ,2 ]
Alfirevic, Zarko [3 ]
机构
[1] Rigshosp, Copenhagen Univ Hosp, Dept Fetal Med, DK-2100 Copenhagen, Denmark
[2] Fac Hlth Sci, Copenhagen, Denmark
[3] Univ Liverpool, Liverpool Womens Hosp, Div Perinatal & Reprod Med, Liverpool L69 3BX, Merseyside, England
关键词
Amniocentesis; Chorionic villus sampling; Fetal loss; Prenatal diagnosis; GUIDED INVASIVE PROCEDURES; FETAL LOSS RATE; 2ND-TRIMESTER AMNIOCENTESIS; GENETIC AMNIOCENTESIS; LOSS RATES; FOLLOW-UP; PREGNANCY; ABNORMALITIES; TERMINATION; ANOMALIES;
D O I
10.1159/000271995
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Introduction: As a consequence of the introduction of effective screening methods, the number of invasive prenatal diagnostic procedures is steadily declining. The aim of this review is to summarize the risks related to these procedures. Material and Methods: Review of the literature. Results: Data from randomised controlled trials as well as from systematic reviews and a large national registry study are consistent with a procedure-related miscarriage rate of 0.5-1.0% for amniocentesis as well as for chorionic villus sampling (CVS). In single-center studies performance may be remarkably good due to very skilled operators, but these figures cannot be used for general counselling. Amniocentesis performed prior to 15 weeks had a significantly higher miscarriage rate than CVS and mid-trimester amniocentesis, and also increased the risk of talipes equinovarus. Amniocentesis should therefore not be performed before 15 + 0 weeks' gestation. CVS on the other hand should not be performed before 10 weeks' gestation due to a possible increase in risk of limb reduction defects. Discussion: Experienced operators have a higher success rate and a lower complication rate. The decreasing number of prenatal invasive procedures calls for quality assurance and monitoring of operators' performance. Copyright (C) 2009 S. Karger AG, Basel
引用
收藏
页码:1 / 7
页数:7
相关论文
共 58 条
[2]  
Alfirevic Z., 2003, The Cochrane database of systematic reviews, pCD003252, DOI [10.1002/14651858, DOI 10.1002/14651858.CD003252, 10.1002/14651858.CD003252]
[3]  
[Anonymous], 1976, JAMA-J AM MED ASSOC, V236, P1471
[4]   Comparison between 20G and 22G needle for second trimester amniocentesis in terms of technical aspects and short-term complications [J].
Athanasiadis, Apostolos P. ;
Pantazis, Konstantinos ;
Goulis, Dimitrios G. ;
Chatzigeorgiou, Konstantinos ;
Vaitsi, Violeta ;
Assimakopoulos, Efstratios ;
Tzevelekis, Filippos ;
Tsalikis, Tryfon ;
Bontis, John N. .
PRENATAL DIAGNOSIS, 2009, 29 (08) :761-765
[5]   POPULATION-BASED STUDY OF LONG-TERM OUTCOMES AFTER AMNIOCENTESIS [J].
BAIRD, PA ;
YEE, IML ;
SADOVNICK, AD .
LANCET, 1994, 344 (8930) :1134-1136
[6]   Survey of prenatal screening policies in Europe for structural malformations and chromosome anomalies, and their impact on detection and termination rates for neural tube defects and Down's syndrome [J].
Boyd, P. A. ;
DeVigan, C. ;
Khoshnood, B. ;
Loane, M. ;
Garne, E. ;
Dolk, H. .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2008, 115 (06) :689-696
[7]  
CAHILL A, 2009, AM J OBSTET GYNECOL, V200
[8]   Techniques for chorionic villus sampling and amniocentesis: a survey of practice in specialist UK centres [J].
Carlin, A. J. ;
Alfirevic, Z. .
PRENATAL DIAGNOSIS, 2008, 28 (10) :914-919
[9]   Chorionic villus sampling compared with amniocentesis and the difference in the rate of pregnancy loss [J].
Caughey, Aaron B. ;
Hopkins, Linda M. ;
Norton, Mary E. .
OBSTETRICS AND GYNECOLOGY, 2006, 108 (03) :612-616
[10]   Infant morbidity following amniocentesis and chorionic villus sampling for prenatal karyotyping [J].
Cederholm, M ;
Haglund, B ;
Axelsson, O .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2005, 112 (04) :394-402